COV

Covalon Announces First Quarter Fiscal 2024 Results

Retrieved on: 
Wednesday, February 28, 2024

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 first quarter results for the period ended December 31, 2023.

Key Points: 
  • Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its fiscal 2024 first quarter results for the period ended December 31, 2023.
  • I am extremely proud of the progress that the Covalon team has made in the past few months with a solid focus on strengthening foundational elements for our business and setting the stage for substantial revenue growth in fiscal 2024.
  • In parallel with our intense focus on growth, we are also highly focused on streamlining our operating expenses relative to revenue, with the goal of achieving EBITDA profitability within fiscal 2024.
  • The entire Covalon team is very energized to drive Covalon into its forthcoming growth phase.

Quectel Showcases 5G IoT Innovation at MWC Barcelona 2024

Retrieved on: 
Monday, February 26, 2024

Quectel Wireless Solutions, a global IoT solutions provider, is pleased to announce its participation in the Mobile World Congress (MWC) Barcelona 2024, where it will showcase its IoT solutions alongside collaborations with industry-leading partners.

Key Points: 
  • Quectel Wireless Solutions, a global IoT solutions provider, is pleased to announce its participation in the Mobile World Congress (MWC) Barcelona 2024, where it will showcase its IoT solutions alongside collaborations with industry-leading partners.
  • "Our presence at MWC Barcelona 2024 together with our customers’ applications is a testament to our dedication to innovation and our customers' trust in us to lead the way in 5G technology."
  • MikroTik Chateau 5G Router: Quectel and MikroTik have teamed up to present the Chateau 5G Router, a device that epitomizes the fusion of sophisticated design and powerful 5G connectivity.
  • Attendees can visit the Quectel booth in Hall Five, stand 5A19 at MWC Barcelona 2024 to experience these innovations first-hand and to discuss how 5G technology can revolutionize their businesses and everyday life.

TechImmune to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Tuesday, January 2, 2024

Dr. Ulmer will present a company overview on Wednesday, January 10th at 1:30 PM PST.

Key Points: 
  • Dr. Ulmer will present a company overview on Wednesday, January 10th at 1:30 PM PST.
  • Institutional investors who are interested in attending the presentation should contact their J.P. Morgan representative for registration information.
  • Current vaccines for COVID-19 rely upon immunizing subjects with vaccines targeting the virus surface Spike protein of SARS-CoV-2 for induction of protective antibody responses.
  • Such a broad-spectrum COVID vaccine would obviate the need for frequent updating and boosting, as well as prevent future outbreaks.

Covalon’s VALGuard Gains Prestigious Recognition in the British Journal of Nursing

Retrieved on: 
Wednesday, November 15, 2023

“We are deeply grateful to the British Journal of Nursing for featuring this important work.

Key Points: 
  • “We are deeply grateful to the British Journal of Nursing for featuring this important work.
  • “It’s an honor to see Covalon’s VALGuard being recognized by such a respected journal.
  • A novel, transparent line guard (VALGuard) protects CVAD hubs from gross contamination.
  • British Journal of Nursing.

Covalon Presents Innovative Solutions Used in Top Hospitals at the Association for Vascular Access (AVA) Annual Scientific Meeting in Portland, OR

Retrieved on: 
Friday, October 13, 2023

Visitors to booth 715 will have the opportunity to explore first-hand Covalon’s innovative vascular access and infection prevention solutions and learn more as to why top hospitals are choosing Covalon for their patients.

Key Points: 
  • Visitors to booth 715 will have the opportunity to explore first-hand Covalon’s innovative vascular access and infection prevention solutions and learn more as to why top hospitals are choosing Covalon for their patients.
  • View the full release here: https://www.businesswire.com/news/home/20231013482402/en/
    Covalon's IV Clear® dressing is the world's only dual antimicrobial silicone adhesive vascular access dressing.
  • “Our innovative offering of silicone-based vascular access solutions weave together safety and efficacy with compassion.
  • IV Clear ® - the world’s only dual-antimicrobial vascular access dressing that offers complete transparency at and around the insertion site for easy daily assessment.

Covalon to Showcase Innovative Solutions at the Prestigious ANCC National Magnet Conference in Chicago

Retrieved on: 
Wednesday, October 11, 2023

Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), a leader in advanced medical technologies, today announced its participation in the American Nurses Credentialing Center (ANCC) Magnet Conference.

Key Points: 
  • Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), a leader in advanced medical technologies, today announced its participation in the American Nurses Credentialing Center (ANCC) Magnet Conference.
  • Scheduled from Thursday, October 12 to Saturday, October 14, 2023, in Chicago, this conference is the largest conference for nurse professionals.
  • Covalon offers compassionate care solutions that are effective and gentle on even the most fragile skin.
  • To book an appointment with a Covalon representative, please email Ron Hebert, SVP Marketing, Covalon Technologies Ltd., at [email protected] .

Life with a Central Line [WEBINAR]: Key Considerations from the Patient’s Perspective

Retrieved on: 
Monday, September 25, 2023

The event, scheduled for Wednesday, September 27, 2023, from 1-2 PM EST, is designed to provide attendees with a profound look into the patient’s world – living with central vascular access devices.

Key Points: 
  • The event, scheduled for Wednesday, September 27, 2023, from 1-2 PM EST, is designed to provide attendees with a profound look into the patient’s world – living with central vascular access devices.
  • View the full release here: https://www.businesswire.com/news/home/20230925181300/en/
    Covalon presents a new webinar titled “Central Vascular Access Devices: Key Considerations from the Patient’s Perspective”, featuring speakers Jessika Buehne and Chalice Richert, to be held on Wednesday, September 27, 2023, at 1 – 2 PM EST.
  • “The approach Covalon is taking to listen and amplify the voice of patients speaks volumes,” said Jessika Buehne.
  • Knowing hospitals and device companies are listening gives me hope.” Chalice Richert added, “Finding the right device for your line and skin can make all the difference.

Covalon Showcases Compassionate Pediatric Care Solutions at 47th APHON Conference

Retrieved on: 
Tuesday, September 19, 2023

Covalon invites all attendees to booth 425 at the Huntington Convention Center, where they can explore our compassionate infection prevention solutions tailor made for pediatric patients.

Key Points: 
  • Covalon invites all attendees to booth 425 at the Huntington Convention Center, where they can explore our compassionate infection prevention solutions tailor made for pediatric patients.
  • (Photo: Business Wire)
    “At Covalon, we deeply believe that healing shouldn’t hurt,” said Ron Hebert, Senior Vice President, Marketing, Covalon.
  • We’re proud to introduce our advanced vascular access solutions and dressings to attendees of the APHON Conference.”
    The APHON Conference serves as a nexus for the brightest minds in pediatric hematology/oncology nursing.
  • To book an appointment with a Covalon representative, please email Ron Hebert, SVP Marketing, Covalon Technologies Ltd., at [email protected] .

Premier Medical Journal Spotlights Covalon’s VALGUARD: A Novel Solution to Long-Standing Problem of Protecting Vascular Access Sites

Retrieved on: 
Tuesday, July 18, 2023

“At Covalon we’re incredibly grateful to JAVA and Darcy for bringing greater awareness to how Covalon’s VALGuard product can protect and empower more patients receiving vascular access care.

Key Points: 
  • “At Covalon we’re incredibly grateful to JAVA and Darcy for bringing greater awareness to how Covalon’s VALGuard product can protect and empower more patients receiving vascular access care.
  • The majority of CLABSIs are preventable, and strengthening infection protection bundles with improved practices and new technology is a proven approach.
  • Doellman, D. Guarding the Central venous Access Device: A New Solution for an Old Problem.
  • Journal of the Association for Vascular Access.

Covalon Announces Participation in Oley Conference in St. Louis, Missouri on June 27 – 30, 2023

Retrieved on: 
Tuesday, June 27, 2023

Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its participation in the 2023 Annual Oley Foundation Conference being held in St. Louis, Missouri from Tuesday, June 27 to Friday, June 30, 2023.

Key Points: 
  • Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its participation in the 2023 Annual Oley Foundation Conference being held in St. Louis, Missouri from Tuesday, June 27 to Friday, June 30, 2023.
  • View the full release here: https://www.businesswire.com/news/home/20230627972227/en/
    IV fluid line secured to the forearm with IV Clear®, a soft dual-antimicrobial silicone IV securement dressing offered by Covalon.
  • “For those relying on parenteral nutrition, their IV is a lifeline, but it can also be a direct line to infection, pain, and trauma.
  • The conference brings together clinicians, patients, and industry to facilitate knowledge sharing on tube feeding and IV nutrition.